ANIMATION

Heart Sciences MyoVista Wavelet ECG Technology

Share this animation:

Coronary heart disease, or CHD, is a leading cause of death in men and women, effecting an estimated 16.5 million adults in the United States. Due to its limitations, current ECG testing leaves many patients undiagnosed.

XVIVO partnered with Heart Sciences to develop an animation describing their MyoVista Wavelet ECG technology that can detect changes in the heart from CHD and other diseases before symptoms appear.

MyoVista Wavelet ECG is revolutionizing conventional electrocardiography, providing significant clinical, technical, and economical advantages for healthcare providers over conventional ECG. This technology now provides physicians more information to enable better risk stratification to identify heart disease earlier.

Share It:
Contact XVIVO

Client


Heart Sciences MyoVista Wavelet ECG Technology

XVIVO was asked to create an extremely complex but biochemically and biologically accurate animation that depicted the role of neuropeptides in brain plasticity. The final product was astounding — far beyond our expectations. This animation is now being used to educate breast cancer survivors on how cognitive processes are restored after chemotherapy. I would highly recommend XVIVO to others seeking similar products.

Lyn Freeman, Ph.D., CEO, Mind Matters Research, LLC
Share this animation: